Skip to content
Brilliant Blue Biosciences logoBrilliant BlueBiosciences
← Research & Industry News
External source

GBI prepares a smaller-scale route to GMP supply

GBI plans to introduce SmartScale, a service aimed at early-stage developers seeking GMP material for clinical development. The announcement concerns a product, collaboration or production plan; it does not by itself establish clinical benefit or verified scale-up performance.

Published by
GEN — Genetic Engineering & Biotechnology News
Evidence type
Industry

GEN reports: GBI plans to introduce SmartScale, a service aimed at early-stage developers seeking GMP material for clinical development.

The announcement concerns a product, collaboration or production plan; it does not by itself establish clinical benefit or verified scale-up performance. Consult the linked GEN report for the source organisation’s full announcement.

Manufacturing & Translation

Let's engineer the next delivery breakthrough together

We co-develop nanocarrier and biosensing programmes with pharma, biotech and academic groups — from target selection through GMP supply.

ResearchersRequest a technical consultationTalk formulation, characterisation or assay design with one of our scientists.Industry partnersExplore co-developmentFeasibility studies, co-development programmes, licensing and GMP supply.InvestorsDownload our capabilities deckPlatform, pipeline milestones, manufacturing and partnership models in one PDF.

Prefer to talk it through? Book a 30-minute discovery call

GBI prepares a smaller-scale route to GMP supply | Brilliant Blue Biosciences